CTS Corp director granted 3,500 RSUs; now holds 12,200 shares
CTS Corp (CTS) reported a director equity grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
CTS Corp (CTS) reported a director equity grant. On 11/06/2025, a director acquired 3,500 shares of common stock at $0 (code A), reported as a grant of restricted stock units.
The filing notes these RSUs vest 100% on the first anniversary of the grant date, contingent on continued service as a director through the vesting date. After the transaction, the reporting person beneficially owns 12,200 shares, held directly.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 3,500 | $0.00 | $0.00 |
Footnotes (1)
- F1. Restricted stock units vest 100% on the first anniversary of the grant date, contingent upon the recipient's continued service as a director through the vesting date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did CTS (CTS) disclose in this Form 4?
What is the vesting schedule for the CTS director’s RSUs?
What transaction code was used in the CTS Form 4?
Was there a purchase price for the CTS RSUs?
What is the ownership form reported for the CTS holdings?
AI-generated analysis. How Rhea-AI works. Not financial advice.